top of page
Interim analysis of the EYE strategy

Content Editor: Dr. Himabindu Reddy

November 29, 2023 at 12:30:00 PM

Vaccination, Global health, Yellow fever, International health

Content Editor: Dr. Himabindu Reddy

  • Under the guidance of WHO, UNICEF, and Gavi evaluation offices, the Euro Health Group conducted an independent mid-term evaluation of the EYE Strategy.

  • This evaluation was conducted in order to assess the strategy's current state of development.

  • The evaluation also aimed to identify the most effective path forward for safeguarding nearly 1 billion people in Africa and the Americas from yellow fever by 2026.

  • The evaluation covered the EYE strategy from 2017 to 2021.

  • Data from the EYE Strategy shows that since 2017, 226 million more Africans have received a single-dose vaccination that offers lifetime protection against yellow fever.

  • The EYE partners reiterate that they are dedicated to stepping up their efforts in order to:

  1. Assist countries in putting the strategy into practice

  2. Prevent all further yellow fever outbreaks worldwide by 2026

  • The Vaccine Alliance assured that it will keep collaborating with nations and partners to support:

  1. Routine immunization

  2. Close immunization gaps

  3. Enhance preparedness for responding to outbreaks

bottom of page